Dynavax Technologies
DVAX
#4993
Rank
NZ$3.12 B
Marketcap
NZ$26.64
Share price
0.00%
Change (1 day)
15.33%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -NZ$63.57 Million

According to Dynavax Technologies 's latest financial reports the company's current earnings are NZ$0.33 Billion. In 2024 the company made an earning of NZ$64.7 Million, an increase over its 2023 earnings that were of NZ$4.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$63.57 Million-198.22%
2024 NZ$64.7 M1475.31%
2023 NZ$4.1 M-99.2%
2022 NZ$0.51 B238.78%
2021 NZ$0.15 B-257.89%
2020 -NZ$96.56 Million-58.58%
2019 -NZ$0.24 Billion-9.32%
2018 -NZ$0.26 Billion60.44%
2017 -NZ$0.17 Billion-15.8%
2016 -NZ$0.2 Billion4.22%
2015 -NZ$0.19 Billion16.54%
2014 -NZ$0.16 Billion37.09%
2013 -NZ$0.12 Billion
2010 -NZ$81.8 Million214.85%
2009 -NZ$25.98 Million-37.33%
2008 -NZ$41.46 Million-66.07%
2007 -NZ$0.13 Billion16.92%
2006 -NZ$0.11 Billion170.36%
2005 -NZ$38.66 Million33.39%
2004 -NZ$28.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$18.20 B-31,352.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.61 B-26,914.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$2.78 B-4,889.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$16.83 B-29,009.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$22.60 B-38,910.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$25.20 B-43,371.95%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$17.20 B-29,642.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
NZ$35.51 M-160.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.90 B-6,801.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel